Corneal cross-linking treatment of keratoconus
Keratoconus as the most common cause of ectasia is one of the leading cause of corneal transplants worldwide. The current available therapies do not modify the underlying pathogenesis of the disease, and none of the available approaches but corneal transplant hinder the ongoing ectasia. Several stud...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | Oman Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.ojoonline.org/article.asp?issn=0974-620X;year=2015;volume=8;issue=2;spage=86;epage=91;aulast=Farjadnia |
id |
doaj-47b6c1bc10ba45c5bdf7b0a7b5be99d1 |
---|---|
record_format |
Article |
spelling |
doaj-47b6c1bc10ba45c5bdf7b0a7b5be99d12020-11-24T23:09:15ZengWolters Kluwer Medknow PublicationsOman Journal of Ophthalmology0974-620X2015-01-0182869110.4103/0974-620X.159105Corneal cross-linking treatment of keratoconusMahgol FarjadniaMohammad NaderanKeratoconus as the most common cause of ectasia is one of the leading cause of corneal transplants worldwide. The current available therapies do not modify the underlying pathogenesis of the disease, and none of the available approaches but corneal transplant hinder the ongoing ectasia. Several studies document Crosslink defect between collagen fibrils in the pathogenesis of keratoconus. Collagen cross link is a relatively new approach that with the application of the riboflavin and ultraviolet A, new covalent bands reform. Subjective and objective results following this method seem to be promising. Endothelial damage besides other deep structural injury, which is the major concern of this technique have not yet been reported, when applying the standard method.http://www.ojoonline.org/article.asp?issn=0974-620X;year=2015;volume=8;issue=2;spage=86;epage=91;aulast=FarjadniaCorneal cross linkingkeratoconusultraviolet A |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mahgol Farjadnia Mohammad Naderan |
spellingShingle |
Mahgol Farjadnia Mohammad Naderan Corneal cross-linking treatment of keratoconus Oman Journal of Ophthalmology Corneal cross linking keratoconus ultraviolet A |
author_facet |
Mahgol Farjadnia Mohammad Naderan |
author_sort |
Mahgol Farjadnia |
title |
Corneal cross-linking treatment of keratoconus |
title_short |
Corneal cross-linking treatment of keratoconus |
title_full |
Corneal cross-linking treatment of keratoconus |
title_fullStr |
Corneal cross-linking treatment of keratoconus |
title_full_unstemmed |
Corneal cross-linking treatment of keratoconus |
title_sort |
corneal cross-linking treatment of keratoconus |
publisher |
Wolters Kluwer Medknow Publications |
series |
Oman Journal of Ophthalmology |
issn |
0974-620X |
publishDate |
2015-01-01 |
description |
Keratoconus as the most common cause of ectasia is one of the leading cause of corneal transplants worldwide. The current available therapies do not modify the underlying pathogenesis of the disease, and none of the available approaches but corneal transplant hinder the ongoing ectasia. Several studies document Crosslink defect between collagen fibrils in the pathogenesis of keratoconus. Collagen cross link is a relatively new approach that with the application of the riboflavin and ultraviolet A, new covalent bands reform. Subjective and objective results following this method seem to be promising. Endothelial damage besides other deep structural injury, which is the major concern of this technique have not yet been reported, when applying the standard method. |
topic |
Corneal cross linking keratoconus ultraviolet A |
url |
http://www.ojoonline.org/article.asp?issn=0974-620X;year=2015;volume=8;issue=2;spage=86;epage=91;aulast=Farjadnia |
work_keys_str_mv |
AT mahgolfarjadnia cornealcrosslinkingtreatmentofkeratoconus AT mohammadnaderan cornealcrosslinkingtreatmentofkeratoconus |
_version_ |
1725610742376300544 |